Shibani Naik

Shibani Naik, Ph.D., is a seasoned scientist and manager currently leading operations for a Phase 3 project at Emergent BioSolutions since January 2022. With extensive experience in preclinical and clinical development, Shibani Naik has previously advanced antiviral candidates for Arenavirus and Ebolavirus at Arisan Therapeutics, Inc., held positions from Research Associate to Senior Scientist, and executed various in vitro studies. Early career experiences include contributions to cancer-targeted therapeutics and biomarker development, alongside training in molecular diagnostics. Shibani Naik earned a PhD in Immunobiology from Iowa State University and holds a B Tech in Biotechnology from Jaypee University of Information Technology.